We use cookies. EPF Congress uses cookies to make sure you get the best experience on our website.

The congress' contributors

The congress' Contributors

Jean-Christophe Tellier

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, Vice-President as well as President-Elect of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Chairman of the Innovation Board Sponsored Committee (EFPIA) and Chairman of the Innovative Medicines Initiative (IMI) Governing Board. He is also a member of the Board of

PhRMA (Pharmaceutical Research and Manufacturers of America) and of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 25-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents.

Speaking in:
Plenary session: Patient involvement - presenting the evidence


Learn more about Thomas Allvin

Thomas Allvin

Executive Director for Strategy and Healthcare Systems at the European Federation of Pharmaceutical Industries and Associations (EFPIA)

Thomas Allvin
Learn more about Alice Casagrande

Alice Casagrande

Director, formation, innovation et vie associative, Fédération des Etablissements Hospitaliers et d'Aide à la Personne, Privés Non Lucratifs

Alice Casagrande
Learn more about Elena Petelos

Elena Petelos

Lecturer in Evidence-Based Medicine and Evidence Informed Policy, AdBoard of the European Forum for Primary Care, GovBoard of the European Public Health Association

Elena Petelos

More speakers Announced soon

Please check back later for updates.


Learn more about June Raine

June Raine

Director of Vigilance and Risk Management of Medicines at the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK

June Raine
Learn more about Miklós Szócska

Miklós Szócska

Former Secretary of State for Health in Hungary, Director of the Health Services Management Training Centre of the Semmelweis University

Miklós Szócska

Master of Ceremonies

Patients included

We are proud to announce that EPF Congress 2019 is Patients Included™. This means that EPF is committed to incorporating the experience of patients as experts in living with their condition while ensuring they were neither excluded nor exploited.

More information